TECHNIQUES AND METHODS |
|
|
|
|
Location of EGFP Tag Affects the Binding Activity of Peptide Fusions |
WANG Hai, SHI Bi-zhi, YANG Sheng-li, LI Zong-hai, LUO Xiao-ying |
State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Cancer Institute, Shanghai 200032, China |
|
|
Abstract Purpose: To investigate whether the location between targeting peptide and tag protein (eGFP) would influence the binding capacity of fusing protein to cell. Methods: To get Ge11 and LyP1 fusing eGFP recombination protein by expressing system in E coli. respectively, and then put the recombination protein into the medium of serum starving SMMC-7721 liver cancer cell line, after treating 3 hours, to detect the binding capacity by Fluorescence microscopy. Results: when eGFP at the Carboxyl terminal of targeting peptides, the recombination protein could bind to the cell; But when eGFP at the Nitro terminal, the recombination protein loss the binding capacity. On the basis of these researches, the other 3 targeting peptides were detected. Conclusion: These results indicate that an inappropriate fusion strategy would lead to decreased or even totally loss of function of targeting peptides. Thus, it should be cautious when used EGFP as a tracer to study the targeting activities of peptides.
|
Received: 15 February 2012
Published: 25 June 2012
|
|
|
|
[1] Aima O H, Liu R, Sutcliffe J L, et al. Combinatorial chemistry to cancer-targeting peptides. Mol Pharmaceut, 2007,4:631-651. [2] Arap W A, Pasqualini R, Ruoslanti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 1998,279:377-380. [3] Yao V J, Pzawa M G, Varner A S, et al. Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels. Cancer Res, 2006,66:2639-2649. [4] Du B, Qin M, Zhou Z, et al. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem Bioph Res Co, 2006,342:956-962. [5] Oyama T, Sykes K F, Samli K N, et al. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett, 2003,202:219-230. [6] Hong F D, Clayman G L. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res, 2000,60:6551-6556. [7] Laakkonen P, Porkka K, Hoffman J A, et al. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med, 2002,8:751-755. [8] Fukuda M N, Ohyama C, Lowitz K, et al. A peptide mimic of e-selectin ligand inhibits sialyl lewis x-dependent lung colonization of tumor cells. Cancer Res, 2000,60:450-456. [9] Wang X F, Birringer M, Dong L F, et al. A peptide conjugate of vitamin E succinate targets breast cancer cells with high erbb2 expression. Cancer Res, 2007,67:3337-3334. [10] Shadidi M, Sioud M. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J, 2002,17:256-258. [11] Medina-Kauwe L K, Leung V, Wu L, et al. Assessing the binding and endocytosis activity of cellular receptors using GFP-ligand fusions. BioTechniques, 2000,29:602-609. [12] Cormack B P, Valdivia R H, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene, 1995,173: 33-38. [13] Heim R, Cubitt A B, Tsien R Y. Improved green fluorescence. Nature, 1995,373: 663-664. [14] Zhang G, Gurtu V, Kain S R. An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Bioph Res Co, 1996, 227: 707-711. [15] Jiang H, Zhang J, Shi B Z, et al. Application of EGFP-EGF fusions to explore mechanism of endocytosis of epidermal growth factor. Acta Pharmacol Sin, 2007, 28:111-117. [16] Li Z H, Zhao R, Wu X H, et al. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J, 2005,19:1978-1985. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|